Author

Ximena López

Every paper listing this name carries an ORCID.

Identified by ORCID

Ximena LópeziD1 paper · Fundación Ciencia and Vida

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Álvaro LladseriD· 1 shared Andrés Hernández‐OliverasiD· 1 shared Diego A. FigueroaiD· 1 shared Fabiola OsorioiD· 1 shared Felipe Ardiles· 1 shared Felipe Flores· 1 shared Felipe Gálvez‐CancinoiD· 1 shared Hugo GonzáleziD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Álvaro LladserORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Long-term efficacy of adoptive cell therapy is determined by host CD8+ T cells and undermined by lymphodepleting preconditioning

Diego A. Figueroa, Juan Pablo Vega, Andrés Hernández‐Oliveras, Felipe Gálvez‐Cancino, Felipe Ardiles, Felipe Flores, Sofía Hidalgo, Ximena López, Hugo González, Fabiola Osorio, Vincenzo Borgna, Álvaro Lladser

This study shows that host CD8+ T cells enhance adoptive cell therapy (ACT) efficacy against melanoma, while lymphodepleting preconditioning reduces long-term effectiveness by impairing host immunity.

bioRxiv · May 16, 2024 · PreprintImmunology